New genetic screen paves the way for long-sought treatments for liver disease

April 11, 2013

Chronic liver failure is a major health problem that causes about one million deaths around the world each year. A study published April 11th by Cell Press in the journal Cell reveals a new type of screen for identifying genes that promote liver repair in mouse models of both acute and chronic liver disease. The study shows that the MKK4 gene could be a promising therapeutic target to enhance liver regeneration and provides a blueprint for future studies aimed at discovering new therapies for liver disease.

"It is now conceivable to develop specific pharmacological inhibitors of MKK4 in order to treat patients with liver disease," says senior study author Lars Zender of University Hospital Tuebingen. "Such treatment strategies are urgently needed in the clinic, as currently the only curative treatment option for patients with end-stage liver disease is , and the number of donors is limited."

is caused by infections with hepatitis B or C virus, as well as alcohol abuse and malnutrition. Typically, the liver can repair itself after injury by increasing the production of cells called hepatocytes, but serious disease can interfere with this process and ultimately result in liver failure.

To identify potential targets for treating liver disease, Zender and his team developed an unbiased screen to search for genes that regulate in animal disease models. After interfering with the expression of hundreds of genes in mouse livers, they found that MKK4 inhibition increased the production and survival of hepatocytes after acute and chronic , resulting in healthier livers and an increase in the long-term survival of mice. Moreover, MKK4 inhibition increased the survival and long-term viability of hepatocytes in culture, offering a much-needed strategy for improving cell transplantation in patients with liver disease.

"Based on previous studies, we would not have guessed that MKK4 would strongly influence liver regeneration," Zender says. "Our study shows that genetic screens are a powerful way to search for genes, without any preconceived notions, to identify therapeutic targets that can be used to enhance the regenerative capacity of tissues."

Explore further: Scientists shed light on how liver repairs itself

More information: Wuestefeld et al.: "A direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration." Cell, 2013. dx.doi.org/10.1016/j.cell.2013.03.026

Related Stories

Recommended for you

Formaldehyde damages proteins, not just DNA

September 29, 2016

The capacity of formaldehyde, a chemical frequently used in manufactured goods such as automotive parts and wood products, to damage DNA, interfere with cell replication and cause cancer inspired new federal regulations this ...

Synthetic 3D-printed material helps bones regrow

September 28, 2016

A cheap and easy to make synthetic bone material has been shown to stimulate new bone growth when implanted in the spines of rats and a monkey's skull, researchers said Wednesday.

Epigenetic clock predicts life expectancy

September 28, 2016

UCLA geneticist Steve Horvath led a team of 65 scientists in seven countries to record age-related changes to human DNA, calculate biological age and estimate a person's lifespan. A higher biological age—regardless of chronological ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.